Company / Capital Returned to Shareholders
CONMED Corporation Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$24.7M
FY2025
5-year range
$22.6M / $24.7M
FY2021-FY2025
Trend
+0.4%
vs FY2024
Sector context
#80 of 108
Health Care
What the data says
At $25M, CONMED Corporation's capital returned to shareholders ranks #80 of 108 in the Health Care sector. Capital Returned to Shareholders has increased for 8 consecutive years, from $22M in FY2017 to $25M in FY2025.
Based on SEC 10-K filings.
$25M in FY2025 with a 5-year CAGR of +2.0%.
Remained stable around $25M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
#80 of 108 in Health CareTop 74% of 108This company $24.7M Sector average $754.9M
▼
-96.7% below sector average
Key checks
Key Insights
- CONMED Corporation's capital returned to shareholders has grown for 8 consecutive years.
- 5-year CAGR of +2.0%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 0.4% year-over-year.
- Ranks #80 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.7M | +0.4% |
| FY2024 | $24.7M | +0.6% |
| FY2023 | $24.5M | +7.4% |
| FY2022 | $22.8M | +1.0% |
| FY2021 | $22.6M | +0.7% |
| FY2020 | $22.4M | +0.6% |
| FY2019 | $22.3M | +0.4% |
| FY2018 | $22.2M | +0.5% |
| FY2017 | $22.1M | -43.1% |
| FY2016 | $38.8M | +75.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026